Yamina Krossa Foundation Donor Event: Progress in Research and Clinical Trial Advancements

Description

The Yamina Krossa Fund supports groundbreaking research led by Professor Dr. Ir. Damya Laoui, focusing on a personalized immunotherapy targeting tumor metastasis. This potential "vaccine" is tailored to each individual's tumor, offering a promising treatment with fewer side effects than current methods. The team aims to bring this innovative therapy into clinical trials. The fund's goal is to raise the necessary financial support to advance this therapy to the next phase of development.

The event was organized for donors of the Yamina Krossa Fund to inform them of the latest developments in the research and to highlight the progress being made toward clinical trials.

Period	12 Oct 2024
Event type	Conference